Science


Posts filtered by tags: Pharmaceuticals industry[x]


 

Homegrown Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind.While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and donors to ensure fair access to Covid-19 vaccines for low- and middle-income countries, has said it will miss its target to distribute 2bn doses g...
Tags: Health, Europe, Business, Science, Biology, Indonesia, Saudi Arabia, China, Singapore, India, Africa, Americas, Senegal, European Union, Society, World news


Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind.While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and donors to ensure fair access to Covid-19 vaccines for low- and middle-income countries, has said it will miss its target to distribute 2bn doses g...
Tags: Health, Europe, Business, Science, Biology, Indonesia, Saudi Arabia, China, Singapore, India, Africa, Americas, Senegal, European Union, Society, World news


Latest developments in medical treatment for coronavirus

After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promiseCoronavirus – latest updatesSee all our coronavirus coverageThe first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential game-changer that could provide a new way to protect the most vulnerable people from the worst effects of Covid-19. Molnupiravir joins a growing list of medicines that have shown promise. Here are some...
Tags: Europe, Business, Japan, Science, Drugs, Singapore, India, UK News, World news, Australia news, US news, Medical Research, Asia Pacific, South and Central Asia, Infectious Diseases, Switzerland


Coronavirus treatments: the potential ‘game-changers’ in development

After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promiseCoronavirus – latest updatesSee all our coronavirus coverageThe first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential gamechanger that could provide a new way to protect the most vulnerable people from the worst effects of Covid-19. Molnupiravir joins a growing list of medicines that have shown promise. Here are some ...
Tags: Europe, Business, Japan, Science, Drugs, Singapore, India, UK News, World news, Australia news, US news, Medical Research, Asia Pacific, South and Central Asia, Infectious Diseases, Switzerland


Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad• Coronavirus – latest updates• See all our coronavirus coverageEngland’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British vaccine trial volunteers, the Observer can reveal.Jonathan Van-Tam made the extraordinary proposal after months of uncertainty for the 19,000 volunteers ...
Tags: Health, Europe, UK, England, Science, Drugs, Eu, European Union, Society, UK News, World news, Medical Research, Pharmaceuticals industry, Vaccines and immunisation, Novavax, Jonathan Van Tam


A year that changed the world – and medical companies’ fortunes

While Covid sent many firms to the wall, others prospered by spotting opportunities, from test kits to mask coatingsThe pandemic has taken a heavy toll on business, gutting high streets as familiar names fell into receivership. But for some less well-known firms, the past 18 months have been transformational. Those that have thrived did so by carving out a new niche – with products as varied as Covid sequencing technology kits and surgical masks with virus-killing coatings. We asked some of them...
Tags: Health, Business, Science, Investing, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, COVID


UK regulator approves ‘first of its kind’ Covid antibody treatment

Sajid Javid says green light for Ronapreve – which was used to treat Donald Trump – is ‘fantastic news’Coronavirus – latest updatesSee all our coronavirus coverageThe antibody cocktail used to treat Donald Trump for Covid has been approved by the UK’s medicines regulator, becoming the first treatment in Britain using artificial antibodies to tackle the virus.The drug, developed by the US biotech company Regeneron, has received the backing of the Medicines and Healthcare products Regulatory Agenc...
Tags: Health, Business, Politics, UK, Science, US, Society, UK News, World news, Medical Research, Britain, Infectious Diseases, Health policy, Pharmaceuticals industry, Sajid Javid, Donald Trump


UK approves rollout of ‘first of its kind’ Covid antibody treatment

Ronapreve can be used to treat symptoms of acute infection after successful clinical trialsCoronavirus – latest updatesSee all our coronavirus coverageThe medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19.The health secretary, Sajid Javid, said approval of the first drug designed specifically for coronavirus in the country is “fantastic news” and he hoped it could be rolled out for patients on the NHS as soon as possib...
Tags: Health, Business, Politics, UK, Science, Biology, Society, UK News, World news, Medical Research, Infectious Diseases, NHS, Microbiology, Pharmaceuticals industry, Vaccines and immunisation, Sajid Javid


UK orders extra Covid vaccines for autumn 2022 booster campaign

Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaitedCoronavirus – latest updatesSee all our coronavirus coverageMinisters have started ordering vaccines for a booster campaign in autumn 2022, with Pfizer reportedly being asked to supply the UK with a further 35m doses.The government has still not give the final go-ahead for the vaccine booster programme expected this autumn, but it is understood to have placed the order with Pfizer despite...
Tags: Health, Business, Politics, UK, Science, Society, UK News, Public services policy, Medical Research, Infectious Diseases, Microbiology, Health policy, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Coronavirus


Covid drug could help reduce heavy menstrual bleeding

Trial suggests anti-inflammatory dexamethasone may offer welcome alternative to intra-uterine systemResearchers hope a steroid that shot to prominence during the Covid pandemic may help reduce blood loss in those who experience heavy periods.The cheap anti-inflammatory dexamethasone was discovered to improve survival rates among patients critically ill with Covid. It is also used for conditions including severe asthma and certain forms of arthritis. Continue reading...
Tags: Health, Science, Women, UK News, Medical Research, Pharmaceuticals industry, Menstruation


As Delta spreads, Pfizer and Moderna get set for a booster shot to profits

The firms are already taking the lion’s share of earnings from the market, as this week’s results will showPraised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies.In June, analysts estimated the global market for the vaccines could be worth $70bn (£50bn) this year, but the figure could be even higher as the Delta variant of coronavirus spreads and scientists debate whether peopl...
Tags: Business, Science, Medical Research, Infectious Diseases, Delta, Astrazeneca, Pharmaceuticals industry, Pfizer, Moderna, Coronavirus


Centre Court ovations, limbo-dancing grans – it’s all been humbling, say Oxford vaccine creators

Sarah Gilbert and Catherine Green tell of their pioneering vaccine work but warn the battle is far from overCoronavirus – latest updatesSee all our coronavirus coverageSarah Gilbert’s experiences at Wimbledon last week clearly had a profound impact on the medical researcher – though it was not the standing ovation that the vaccine pioneer received on Centre Court that turned her head. It was the sleekly efficient operations she experienced at the tennis championships that most impressed her.“Eve...
Tags: Health, Science, Oxford, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Wimbledon, Sarah Gilbert, Gilbert, Centre Court, Catherine Green, Coronavirus


The Oxford vaccine: the trials and tribulations of a world-saving jab

Amid bemusement from scientists at the deluge of often undeserved criticism, the Guardian pieces together the story behind the vaccine’s successes and failuresCoronavirus – latest updatesSee all our coronavirus coverageIn January 2020, when most of the world slept soundly in ignorance of the pandemic coming its way, a group of scientists at Oxford University got to work on a vaccine to save the planet. They wanted it to be highly effective, cheap, and easy to use in even the poorest countries.Pr...
Tags: Health, Science, Media, UK News, World news, Infectious Diseases, Oxford, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Sarah Gilbert Prof Andrew Pollard, Anglo Swedish pharmaceutical company AstraZeneca


Covid jabs for billions of humans will earn their makers billions of dollars

We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination driveCoronavirus – latest updatesSee all our coronavirus coverageDrugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this year and next, given G7 governments’ pledge to vaccinate the entire world by the end of 2022, but sales are likely to drop sharply thereafter, according to analysts.Acclaimed for allowing a ...
Tags: Health, Business, Science, US, Society, World news, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus, Karen Andersen, Morningstar Continue


German scientists say they can help improve vaccines to prevent blood clots

AstraZeneca and Johnson & Johnson jabs have caused rare blood clots but scientists say they can be redesigned to avoid problemCoronavirus – latest updatesSee all our coronavirus coverageA team of German scientists believe that they have worked out why some people given the AstraZeneca and Johnson & Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve the vaccine to avoid it.The key is in the adenovirus – the common cold virus that is us...
Tags: Science, UK News, Frankfurt, Astrazeneca, Pharmaceuticals industry, Johnson Johnson, Goethe, Moderna, Coronavirus, Pfizer BioNTech, Rolf Marschalek


German scientists say they can help improve Covid vaccines to prevent blood clots

AstraZeneca and Johnson & Johnson jabs have caused rare blood clots but scientists say they can be redesigned to avoid problemCoronavirus – latest updatesSee all our coronavirus coverageA team of German scientists believe that they have worked out why some people given the AstraZeneca and Johnson & Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve the vaccine to avoid it.The key is in the adenovirus – the common cold virus that is us...
Tags: Science, UK News, Frankfurt, Astrazeneca, Pharmaceuticals industry, Johnson Johnson, Goethe, Moderna, Coronavirus, Pfizer BioNTech, Rolf Marschalek


What Covid vaccines does the UK have and which are in the works?

As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updatesSee all our coronavirus coverageVaccines to protect against the coronavirus were designed, tested and manufactured in record time, and several have been approved for use in the UK vaccination programme, with a number of others under consideration. Continue reading...
Tags: Health, UK, Science, Scotland, Society, UK News, Britain, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Coronavirus


Global Covid vaccine rollout threatened by shortage of vital components

Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grownCoronavirus – latest updatesSee all our coronavirus coverageVaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s jab supply.Stan Erck, the chief executive of Novavax – which makes the second vaccine to be grown and bottled entirely in Britain – told the Observer that the sh...
Tags: Health, Business, UK, Science, Biology, Society, World news, Medical Research, Britain, Infectious Diseases, Microbiology, Pharmaceuticals industry, Vaccines and immunisation, Novavax, Coronavirus, Stan Erck


Medicines watchdog says no decision made on AstraZeneca jab for under-30s

Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clotsCoronavirus – latest updatesSee all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca vaccine following reports it is considering restricting use of the vaccine in younger people.Channel 4 News reported on Monday evening that the Medicines and Healthcare products Reg...
Tags: Health, UK, Science, UK News, World news, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, Oxford AstraZeneca, Medicines Healthcare products Regulatory Authority


Pfizer vaccine has 91% efficacy for up to six months, trial shows

Findings based on two doses three weeks apart are first to show shot remains effective for many monthsCoronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to six months, an updated analysis of clinical trial data has found.In a statement released on Thursday, the companies reported efficacy of 91.3% against any symptoms of the disease in participants assessed up to six mon...
Tags: Health, Business, Science, Society, World news, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, BioNtech, Coronavirus


Canada suspends use of AstraZeneca Covid vaccine for those under 55

Immunisation panel says there is ‘substantial uncertainty about the benefit’ of the vaccine given risk of rare type of blood clotSee all our coronavirus coverageCanada on Monday suspended the use of the Oxford/AstraZeneca coronavirus vaccine for people under 55 following concerns it might be linked to rare blood clots.The pause was recommended by the National Advisory Committee on Immunization for safety reasons. The Canadian provinces, which administer health in the country, announced the suspe...
Tags: Science, Americas, World news, Canada, Infectious Diseases, Oxford, Astrazeneca, Pharmaceuticals industry, Coronavirus, National Advisory Committee on Immunization


AstraZeneca Covid vaccine is safe and effective, says European regulator

EMA says benefits outweigh risks but also that it is continuing to study possible link with very rare blood clotting disorderCoronavirus – latest updatesSee all our coronavirus coverageThe AstraZeneca coronavirus vaccine is “safe and effective” and its benefits outweigh the risks, Europe’s medicines regulator has said, but it would continue to study possible links between the shot and a very rare blood clotting disorder.The director of the European Medicines Agency (EMA), Emer Cooke, said the ag...
Tags: Health, Europe, Science, Biology, Society, World news, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, EMA, Coronavirus, European Medicines Agency EMA Emer Cooke


Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA

European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend useCoronavirus – latest updatesSee all our coronavirus coverageEurope’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its use.Germany, France, Italy and Spain temporarily halted inoculations with the vaccine on Monday after reported incidents of...
Tags: Health, Europe, Science, France, Germany, Eu, Spain, Infectious Diseases, Italy, Health policy, World Health Organization, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Germany France, Germany France Italy


What price a child's life? India's quest to make rare disease drugs affordable

Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughsFor three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated.Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that affects his organs. Afflicting just one in a million, the enzyme-replacement medication that can help stop the illness getting any worse costs £100,000 a year...
Tags: Health, Business, Science, Biology, India, Society, World news, Genetics, Medical Research, South and Central Asia, Global development, Pharmaceuticals industry, Vidya, Global Health, Children's Health


Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from NorwayCoronavirus – latest updatesSee all our coronavirus coverageIreland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway.The deputy chief medical officer, Dr Ronan Glynn, said Ireland’s advisory body on vaccines had recommended that deployment of the AstraZeneca jab should be “tempo...
Tags: Health, Europe, Business, Science, Biology, Society, World news, Medical Research, Ireland, Infectious Diseases, Microbiology, Oxford, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Norway


From Pfizer to Moderna: who's making billions from Covid-19 vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunesCoronavirus – latest updatesSee all our coronavirus coverageThe arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are both charging more than $30 per person for the protect...
Tags: Health, Business, Science, US, Society, World news, Stock Markets, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus


From Pfizer to Moderna: who's making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunesCoronavirus – latest updatesSee all our coronavirus coverageThe arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are both charging more than $30 per person for the protect...
Tags: Health, Business, Science, US, Society, World news, Stock Markets, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Coronavirus


Covid: Germany and France under pressure to shift Oxford vaccine

Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine dosesCoronavirus – latest updatesSee all our coronavirus coverageAuthorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed in order to avoid a pile-up of unused doses over the coming weeks.On Monday, France’s medical regulator reversed its advice not to use the AstraZeneca jab on over-65s, and Germany’s vaccination committee is coming u...
Tags: Europe, Business, Science, Biology, France, Germany, World news, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Pharmaceuticals industry, Coronavirus


Drug companies look to AI to end 'hit and miss' research

Technology that speeded the development of Covid vaccines has potential to transform the pharmaceutical industryThe hunt for new medicines has often been more like a game of roulette than high-end science. But now the pharmaceutical sector is on the cusp of a transformation, as it delves into cutting-edge technology to come up with new treatments for diseases such as cancer, rheumatoid arthritis and Alzheimer’s.Artificial intelligence (AI) is set to improve the industry’s success rates and speed...
Tags: Business, Science, Technology, Drugs, UK News, Computing, Astrazeneca, Pharmaceuticals industry, GlaxoSmithKline, GlobalData, Artificial intelligence (AI


German politicians counter AstraZeneca vaccine scepticism with show of support

German politicians voice support for jab after only 17% of doses delivered to country are administered so farCoronavirus – latest updates See all our coronavirus coveragePoliticians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed product is threatening to hamper Europe’s Covid-19 immunisation programme.The vaccine, subject of an acrimonious tug-of-war between its British-Swedish manufacturer and the European commission last month...
Tags: Europe, Business, Science, Biology, Germany, World news, Medical Research, Infectious Diseases, Microbiology, Oxford, Astrazeneca, Pharmaceuticals industry, Coronavirus



Filters
show more filters
August - 2021
MoTuWeThFrSaSu
      1
2345678
9101112131415
16171819202122
23242526272829
3031     
September - 2021
MoTuWeThFrSaSu
  12345
6789101112
13141516171819
20212223242526
27282930   
October - 2021
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031